What's Happening?
AustinPx, a contract development and manufacturing organization, has partnered with Thermo Fisher Scientific to expand the commercial access of its KinetiSol Technology. This agreement involves the installation of KinetiSol equipment at Thermo Fisher's
drug manufacturing sites in Bend, Oregon, and Cincinnati, Ohio. KinetiSol is a solvent-free technology designed to enhance the bioavailability of poorly soluble drugs. The collaboration aims to provide a seamless pathway for the development and commercialization of KinetiSol-enabled products, offering pharmaceutical companies a robust solution for challenging drug formulations.
Why It's Important?
This collaboration is crucial for advancing the development of innovative drug delivery solutions. By integrating KinetiSol Technology into Thermo Fisher's manufacturing capabilities, the partnership enhances the ability to bring life-changing medicines to market more efficiently. The agreement provides pharmaceutical companies with greater flexibility in developing therapies, particularly for drugs with poor solubility. This can lead to improved patient outcomes and expanded access to critical treatments. The partnership also underscores the importance of technological innovation in addressing complex pharmaceutical challenges and meeting the growing demand for advanced drug delivery systems.
